SPY Stock analysis and how I am playing SPY stock this week

After sweep of deals in 2023, Gilead to focus on ‘late research, early development’ pipeline

Gilead is still hunting for deals, particularly in virology, oncology and inflammation. During Tuesday’s fourth-quarter earnings call, CEO Daniel O’Day said M&A decisions will be

February 8, 2024

Cerebellar inhibitory interneurons essential for fear memory, study finds

An LSU Health New Orleans research study led by Siqiong June Liu, PhD, Professor of Cell Biology and Anatomy, has found that cerebellar inhibitory interneurons

September 13, 2023

Federal Circuit upholds Novartis patent for heart drug Entresto

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.